sublingual delivery glp-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Frontiers | Glucagon-like peptide-1 receptor
Description
5, e13503
Neither the author nor the publisher assumes liability for the use, interpretation, or implementation of the information contained within this article across third-party platforms
It leverages three powerful pillars: a
doi: 10.2337/db16-0755 [DOI] [PMC free article] [PubMed] [Google Scholar] 47.Lpez-Ojeda W, Hurley RA
Cardiovascular remodeling that occurs during significant weight loss may also provide lasting benefit
Type 2 diabetes is generally (though not exclusively) caused by poor lifestyle and excess body fat, especially that around the mid-section
